BlueStar® Genomic Health Care Index

The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.

Index Parameters

Market Capitalization values are updated daily.

Launch Date: 31 May 2022
Calculator: Standard & Poor's
Dissemination: Realtime
Dissemination Period: 01:00 - 23:00 (CET)
Type: Sector
Currency: USD
Current Components: 79
Base Date: 31 Dec 2015
Base Value: 100
Full Market Cap: 486.76 bn USD
Free-Float Market Cap: 315.88 bn USD
Next Review: 08 Dec 2022

Identifiers

PriceTotal Return Net
ISIN:DE000A30A0C9DE000A3CLKA4
Sedol:BL54GB6BLNPNQ5
WKN:A30A0CA3CLKA
Bloomberg:BDNAPR BDNANTR
Reuters:.BDNAPR.BDNANTR
Valoren:11822730257061641
FIGI:BBG017BXLVR7BBG00TYNPQ94
Up